Aspek Farmakologi dan Indikasi Corticosteroid

Authors

  • Gerry Setiawan Universitas Udayana
  • Ketut Suardamana 1Departemen/KSM Penyakit Dalam, Fakultas Kedokteran Universitas Udayana/RSUP Sanglah, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.55175/cdk.v50i11.623

Keywords:

Anti-inflammatory, corticosteroids, immunosuppressive effect, immunology, steroids

Abstract

Corticosteroids have been widely used in various medical situations and often used for their anti-inflammatory and immunosuppressive effects. Corticosteroids can be given by many routes such as topical, oral, intramuscular, or intravenous. However, prolonged use of steroids can result
in hypothalamic-pituitary-adrenal axis suppression and other side effects. Dosage and using strategy are needed to get the best benefits while minimizing the risk of side effects

Downloads

Download data is not yet available.

References

Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63(6):655–70.

Deng J, Chalhoub NE, Sherwin CM, Li C, Brunner HI. Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum. 2019;49(2):251–9.

Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: A systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009.

Samuel S, Nguyen T, Choi HA. Pharmacologic characteristics of corticosteroids. J Neurocritical Care 2017;10(2):53–9.

Timmermans S, Souffriau J, Libert C. A general introduction to glucocorticoid biology. Front Immunol. 2019;10:1545.

Zava D. Diurnal cortisol curves. ZRT Laboratory [Internet]. [cited 2023 May 6]. Available from: https://www.zrtlab.com/landing-pages/diurnal-cortisol-curves/

Santos RAS, Oudit GY, Verano-Braga T, Canta G, Steckelings UM, Bader M. The renin-angiotensin system: Going beyond the classical paradigms. Am J Physiol Heart Circ Physiol. 2019;316(5):958-70.

Fun Funder JW. Aldosterone and mineralocorticoid receptors-physiology and pathophysiology. Int J Mol Sci. 2017;18(5):1032.

Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress 2018;21(5):403–16.

Ramamoorthy S, Cidlowski JA. Corticosteroids: Mechanisms of action in health and disease. Rheum Dis Clin N Am. 2016;42(1):15–31.

Epstein M. Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: From Hans Selye to the present. Am J Nephrol. 2021;52(3):209-16.

Palmer LG. How does aldosterone work? Kidney 2023;360;4(2):131-3.

Grennan D, Wang S. Steroid side effects. JAMA. 2019;322(3):282.

Liyanage CK, Galappatthy P, Seneviratne SL. Corticosteroids in management of anaphylaxis; A systematic review of evidence. Eur Ann Allerg Clin Immunol. 2017;49(5):196.

Rayanakorn A, Ser HL, Pusparajah P, Chan KG, Goh BH, Khan TM, et al. Comparative efficacy of antibiotic s) alone or in combination of corticosteroids in adults with acute bacterial meningitis: A systematic review and network meta-analysis. PloS One 2020;15(5):e0232947.

Kapugi M, Cunningham K. Corticosteroids. Orthop Nurs. 2019;38(5):336–9.

O'Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P. Asthma progression and mortality: The role of inhaled corticosteroids. Eur Respir J. 2019;54(1):1900491. doi: 10.1183/13993003.00491-2019.

Jiang Z, Zhu L. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2016;37:1–8.

Juel-Berg N, Larsen LF, Küchen N, Norgil I, Hansen KS, Poulsen LK. Patterns of clinical reactivity in a Danish cohort of tree nut allergic children, adolescents, and young adults. Front Allerg 2022;3:31.

Szabo SM, Salhany RM, Deighton A, Harwood M, Mah J, Gooch KL, The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: A systematic literature review. Orphanet J Rare Dis. 2021;16(1):237.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: A randomized clinical trial. JAMA. 2022;327(15):1456-68.

Aoki Y, Miyatake S, Shimizu-Motohashi Y, Takeda S. Anti-inflammatory drugs for Duchenne muscular dystrophy: Focus on skeletal muscle-releasing factors. Drug Des Devel Ther. 2016;10:2745–58.

Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Neuromuscular Group, editor. Cochrane Database Syst Rev [Internet]. 2016 Oct 24 [cited 2022 Apr 26]. Available from: http://doi.wiley.com/10.1002/14651858.CD001446.pub5

Boppana TK, Mittal S, Madan K, Mohan A, Hadda V, Tiwari P, et al. Steroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Monaldi Arch Chest Dis. 2021 Jul 21;91(4). doi: 10.4081/monaldi.2021.1716.

The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704

Fernández-Cruz A, Ruiz-Antorán B, Múñez-Rubio E, Sancho-López A, Callejas-Díaz A, Avendaño-Solá C, et al. The right time for steroids in COVID-19. Clin Infect Dis. 2021;72(8):1486–7

Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Acute Respiratory Infections Group, editor. Cochrane Database Syst Rev [Internet]. 2019 Feb 24 [cited 2022 Apr 22]; Available from: https://doi.wiley.com/10.1002/14651858.CD010406.pub3

Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early short-course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020;71(16):2114–20.

Téblick A, Peeters B, Langouche L, Van den Berghe G. Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol. 2019;15(7):417–27

Hodgens A, Sharman T. Corticosteroids. Treasure Island (FL): StatPearls Publishing; 2023.

Heming N, Annane D. The role of steroids. Management of dysregulated immune response in the critically ill. Springer; 2023 .p. 265-76.

Wen Y, Zhu Y, Jiang Q, Guo N, Cai Y, Shen X. The effectiveness and safety of corticosteroids therapy in adult critical ill patients with septic shock: A meta-analysis of randomized controlled trials. Shock. 2019;52(2):198–207

Rochwerg B, Oczkowski SJ, Siemieniuk RAC, Agoritsas T, Belley-Cote E, D’Aragon F, et al. Corticosteroids in sepsis: An updated systematic review and meta-analysis. Crit Care Med. 2018;46(9):1411–20.

Moskowitz A, Andersen LW, Huang DT, Berg KM, Grossestreuer AV, Marik PE, et al. Ascorbic acid, corticosteroids, and thiamine in sepsis: A review of the biologic rationale and the present state of clinical evaluation. Crit Care. 2018;22(1):283.

Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288(7):862-71.

Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111-24.

Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809-18.

Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797-808.

Lin LL, Gu HY, Luo J, Wang L, Zhang C, Niu YM, et al. Impact and beneficial critical points of clinical outcome in corticosteroid management of adult patients with sepsis: Meta-analysis and grade assessment. Front Pharmacol. 2019;10:1101.

Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock. Chest. 2017;151(6):1229–38.

Liu F, Ji C, Luo J, Wu W, Zhang J, Zhong Z, et al. Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019. Scient Rep. 2020;10(1):13689.

Yu S, Gao Y, Walline JH, Lu X, Zhao L, Li Y. Role of anti-allergic agents on attenuating transfusion reactions in adults: A systematic review and meta-analysis. Transfus Apher Sci. 2021;60(2):103041.

Holt CD. Overview of immunosuppressive therapy in solid organ transplantation. Anesthesiol Clin. 2017;35(3):365–80

Bergmann TK, Barraclough KA, Lee KJ, Staatz CE. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet. 2012;51(11):711–41

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Pregnancy and Childbirth Group, editor. Cochrane Database Syst Rev [Internet]. 2017 Mar 21 [cited 2022 May 1]. Available from: https://doi.wiley.com/10.1002/14651858.CD004454.pub3

Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233–47

Damayanti N, Sumarno S. Glucocorticoid tapering: A literature review. J Islam Pharm. 2020;5(2):1–4

Ismail ZN. Evaluation of fracture risk in Egyptian rheumatoid arthritis patients by the Fracture Risk Assessment Tool. Egyptian Rheumatol Rehabilitation. 2022;49(1):1-0.

Published

01-11-2023

How to Cite

Setiawan, G., & Suardamana, K. (2023). Aspek Farmakologi dan Indikasi Corticosteroid. Cermin Dunia Kedokteran, 50(11), 600–610. https://doi.org/10.55175/cdk.v50i11.623

Issue

Section

Articles